Hetero Launches Colorectal Cancer Drug In India
New Delhi: Drug firm Hetero on Monday launched a biosimilar of 'Bevacizumab', used in treating metastatic colorectal cancer (mCRC), under ...
New Delhi: Drug firm Hetero on Monday launched a biosimilar of 'Bevacizumab', used in treating metastatic colorectal cancer (mCRC), under ...
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.